{{Rsnum
|rsid=1801321
|Gene=RAD51
|Chromosome=15
|position=40695367
|Orientation=plus
|GMAF=0.2663
|Gene_s=DLX3,RAD51
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 27.7 | 52.3 | 20.0
| HCB | 0.0 | 0.0 | 0.0
| JPT | 0.0 | 0.0 | 0.0
| YRI | 0.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21725594
|Title=Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity
}}
{{PMID Auto
|PMID=22613844
|Title=Genetic variability of XRCC3 and RAD51 modulates the risk of head and neck cancer
}}{{PMID Auto
|PMID=12466288
|Title=Haplotype and linkage disequilibrium architecture for human cancer-associated genes.
|OA=1
}}

{{PMID Auto
|PMID=17999359
|Title=RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.
|OA=1
}}

{{PMID Auto
|PMID=18547414
|Title=Genotyping panel for assessing response to cancer chemotherapy.
|OA=1
}}

{{PMID Auto
|PMID=19276285
|Title=Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer.
|OA=1
}}

{{PMID Auto
|PMID=20004634
|Title=Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.
}}

{{PMID Auto
|PMID=20386703
|Title=Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer.
|OA=1
}}
{{PMID Auto
|PMID=24930116
|Title=Association of polymorphisms in the 5' untranslated region of RAD51 gene with risk of endometrial cancer in the Polish population
}}